Lixte Biotechnology Holdings Management
Management criteria checks 2/4
Lixte Biotechnology Holdings' CEO is Bas van der Baan, appointed in Sep 2023, has a tenure of 2.25 years. directly owns 0.49% of the company’s shares, worth €18.01K. The average tenure of the management team and the board of directors is 1.4 years and 4.7 years respectively.
Key information
Bas van der Baan
Chief executive officer
US$624.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.5% |
| Management average tenure | 1.4yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
CEO
Bas van der Baan (52 yo)
less than a year
Tenure
US$623,981
Compensation
Mr. Bastiaan van der Baan, also known as Bas, MSc, served as Independent Director of Lixte Biotechnology Holdings, Inc. from June 17, 2022 until September 26, 2023 and serves as its Chief Executive Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$623.98k | 0.49% $ 18.0k | |
| VP & CFO | 4.1yrs | US$175.00k | 0% $ 0 | |
| VP & COO | 1.8yrs | US$200.00k | 2.08% $ 76.6k | |
| Chief Medical Officer | less than a year | no data | no data |
1.4yrs
Average Tenure
60yo
Average Age
Experienced Management: 8640's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.3yrs | US$623.98k | 0.49% $ 18.0k | |
| Member of Scientific Advisory Committee | 10.7yrs | no data | no data | |
| Director | 8.3yrs | US$70.63k | 0.33% $ 12.2k | |
| Independent Director | 2.3yrs | US$62.50k | 1.11% $ 40.9k | |
| Independent Director | 6.1yrs | US$78.13k | 0.23% $ 8.6k | |
| Independent Director | 3.3yrs | US$78.13k | 0.028% $ 1.0k |
4.7yrs
Average Tenure
70yo
Average Age
Experienced Board: 8640's board of directors are considered experienced (4.7 years average tenure).